The short version
7 companies supply this market — a reasonable cushion if one runs into trouble. A Class II recall hit this product in the past year (Rising Pharma Holding, Inc.). One of its named manufacturing plants, Eugia Pharma Specialities Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.